Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

SOLENO THERAPEUTICS INC

SLNO · — · CIK 0001484565 · Healthcare

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

13 Form 4 transaction lines observed in the same window
0 sales · 13 option, withholding, award, gift or other lines

Last qualifying purchase2023-09-28 · EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · $5.0M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesNone
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Yen KristenSEE REMARKS
○
Volck BirgitteDirector
○
Sinclair AndrewDirector
○
Pauls MatthewDirector
○
Norrett KevinChief Business Officer
○
Manning MeredithChief Commercial Officer
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 7 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2023-09-28 · EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD.

Recent Form 4 activity

0Purchases
6Sales
31Other Form 4 lines
32SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER13 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

The FINRA report lists no short interest for this ticker.

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2023-09-28EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock250,000USD 20.00USD 5,000,000SEC filing ↗
2023-09-26EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock616,789USD 16.40USD 10,113,916SEC filing ↗
2023-06-06EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock200USD 5.93USD 1,186SEC filing ↗
2023-06-05EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock78,468USD 5.98USD 469,239SEC filing ↗
2023-06-02EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock64,630USD 5.93USD 383,256SEC filing ↗
2023-06-01EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock7,500USD 5.59USD 41,925SEC filing ↗
2023-05-31EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock10,000USD 5.28USD 52,800SEC filing ↗
2023-05-30EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock17,500USD 5.34USD 93,450SEC filing ↗
2023-05-26EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)21085922,500USD 5.27USD 118,575SEC filing ↗
2023-05-25EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)21085937,500USD 5.18USD 194,250SEC filing ↗
2023-05-24EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)21085925,000USD 5.48USD 137,000SEC filing ↗
2023-05-23EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock27,500USD 5.45USD 149,875SEC filing ↗
2023-05-22EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock27,300USD 5.12USD 139,776SEC filing ↗
2023-05-19EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTDPurchase (P)Common Stock25,200USD 4.62USD 116,424SEC filing ↗
2022-03-31SCHULER JACK WPurchase (P)Common Stock4,000,000USD —USD —SEC filing ↗

Form 4 evidence

37 transaction lines in the latest 365-day window; 464 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-05-18Yen KristenD (D)Common Stock37,639USD —USD —SEC filing ↗
2026-05-18Volck BirgitteD (D)Common Stock17,536USD —USD —SEC filing ↗
2026-05-18Sinclair AndrewD (D)Common Stock10,491USD —USD —SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-05-18Yen KristenD (D)Common Stock37,639USD —USD —SEC filing ↗
2026-05-18Volck BirgitteD (D)Common Stock17,536USD —USD —SEC filing ↗
2026-05-18Sinclair AndrewD (D)Common Stock10,491USD —USD —SEC filing ↗
2026-05-18Pauls MatthewD (D)Common Stock10,491USD —USD —SEC filing ↗
2026-05-18Norrett KevinD (D)Common Stock17,786USD —USD —SEC filing ↗
2026-05-18Manning MeredithD (D)Common Stock64,507USD —USD —SEC filing ↗
2026-05-18Joshi ManherD (D)Common Stock20,171USD —USD —SEC filing ↗
2026-05-18Huang Michael F.D (D)Common Stock39,823USD —USD —SEC filing ↗
2026-05-18Hirano Patricia CD (D)Common Stock22,702USD —USD —SEC filing ↗
2026-05-18Hahn Mark WD (D)Common Stock10,046USD —USD —SEC filing ↗
2026-05-18Fulk JenniferD (D)Common Stock39,200USD —USD —SEC filing ↗
2026-05-18Bir Dawn CarterD (D)Common Stock16,991USD —USD —SEC filing ↗
2026-05-18Anish BhatnagarD (D)Common Stock583,656USD —USD —SEC filing ↗
2026-03-27Manning MeredithSale (S)Common Stock7,522USD 30.44USD 228,998SEC filing ↗
2026-03-27Huang Michael F.Sale (S)Common Stock6,582USD 30.44USD 200,381SEC filing ↗
2026-03-02Fulk JenniferAward / grant (A)Common Stock39,200USD 0.00USD 0SEC filing ↗
2026-01-21Yen KristenAward / grant (A)Common Stock10,400USD 0.00USD 0SEC filing ↗
2026-01-21Norrett KevinAward / grant (A)Common Stock3,500USD 0.00USD 0SEC filing ↗
2026-01-21Manning MeredithAward / grant (A)Common Stock28,600USD 0.00USD 0SEC filing ↗
2026-01-21Mackaness James HAward / grant (A)Common Stock28,600USD 0.00USD 0SEC filing ↗
2026-01-21Joshi ManherAward / grant (A)Common Stock4,100USD 0.00USD 0SEC filing ↗
2026-01-21Huang Michael F.Award / grant (A)Common Stock10,400USD 0.00USD 0SEC filing ↗
2026-01-21Hirano Patricia CAward / grant (A)Common Stock10,400USD 0.00USD 0SEC filing ↗
2026-01-21Anish BhatnagarAward / grant (A)Common Stock114,200USD 0.00USD 0SEC filing ↗
2025-12-15Yen KristenTax withholding (F)Common Stock904USD 49.95USD 45,155SEC filing ↗
2025-12-15Manning MeredithTax withholding (F)Common Stock1,922USD 49.95USD 96,004SEC filing ↗
2025-12-15Mackaness James HTax withholding (F)Common Stock2,013USD 49.95USD 100,549SEC filing ↗
2025-12-15Huang Michael F.Tax withholding (F)Common Stock812USD 49.95USD 40,559SEC filing ↗
2025-12-15Hirano Patricia CTax withholding (F)Common Stock904USD 49.95USD 45,155SEC filing ↗
2025-12-15Anish BhatnagarGift (G)Common Stock100,000USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerSLNO
CIK0001484565
SectorHealthcare
Industry— Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
Exchange—

Data coverage

Local Form 4 history464 transaction lines from 2020-01-22 to 2026-05-18
41 P purchase lines · 275 S sale lines · 148 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.